Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics [online]. Available from: https://pubmed.ncbi.nlm.nih.gov/12648025/ [accessed 15 August 2021].
Matsuda L., et al. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature [online]. Available from: https://pubmed.ncbi.nlm.nih.gov/2165569/ [accessed 15 August 2021].
Pertwee, R. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology [online]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219532/ [accessed 15 August 2021].
Bergamaschi, M., et al. (2011). Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients. Neuropsychopharmacology [online]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079847/ [accessed 15 August 2021].
Niesink, R., van Laar, M. (2013). Does Cannabidiol Protect Against Adverse Psychological Effects of THC? Frontiers in Psychiatry [online]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797438/ [accessed 15 August 2021].
National Academies of Sciences, Engineering, and Medicine. (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Available from: https://www.ncbi.nlm.nih.gov/books/NBK425767/#_ncbi_dlg_citbx_NBK425767 [accessed 15 August 2021].
Russo, E. (2016). Beyond Cannabis: Plants and the Endocannabinoid System. Trends in Pharmacological Sciences [online]. Available from: https://pubmed.ncbi.nlm.nih.gov/27179600/ [accessed 15 August 2021].
Lu, H, and Mackie, K. (2016). An Introduction to the Endogenous Cannabinoid System. Biological Psychiatry [online]. Available from: https://pubmed.ncbi.nlm.nih.gov/26698193/ [accessed 15 August 2021].
Argenziano, M. et al. (2019). The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases. International Journal of Molecular Sciences [online]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928713/ [accessed 15 August 2021].
Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics [online]. Available from: https://pubmed.ncbi.nlm.nih.gov/12648025/ [accessed 15 August 2021].
Hudson, R, et al. (2019). Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1–2 Phosphorylation. The Journal of Neuroscience [online]. Available from: https://pubmed.ncbi.nlm.nih.gov/31570536/ [accessed 19 August 2021].
MacCallum, C., Russo, E. (2018). Practical Considerations in Medical Cannabis Administration and Dosing. European Journal of Internal Medicine [online]. Available from: https://pubmed.ncbi.nlm.nih.gov/29307505/ [accessed 19 August 2021].
Nielsen, S., Sabioni, P., Trigo, J. et al. (2017). Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis. Neuropsychopharmacology [online]. Available from: https://www.nature.com/articles/npp201751 [accessed 17 November 2021].
Kind Blog - The importance of TGO 93 & TGO 100 for medicinal cannabis quality
Therapeutic Goods Administration. (2019). Therapeutic Goods (Standard for Medicinal Cannabis) (TGO 93) Order 2018 [online]. Available from: https://www.legislation.gov.au/Details/F2019C00328 [accessed 12 January 2022].
Therapeutic Goods Administration. (2018). Therapeutic Goods (Microbiological Standards for Medicines) (TGO 100) Order 2018 [online]. Available from: https://www.legislation.gov.au/Details/F2018L01685 [accessed 12 January 2022].
Kind Blog - Terpenes and their role in medicinal cannabis
Cox-Georgian, D., et al. (2019). Therapeutic and Medicinal Uses of Terpenes. Medicinal Plants: From Farm to Pharmacy [online]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120914/ [accessed 9th of Feb 2022]
Russo, E. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology [online]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/ [accessed 9th of Feb 2022].
LaVigne, J., et al. (2021). Cannabis sativa terpenes are cannabimetric and selectively enhance cannabinoid activity. Scientific Reports [online]. Available from: https://www.nature.com/articles/s41598-021-87740-8 [accessed 9th of Feb 2022].
Piomelli, D., Russo, E. (2016). The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and Cannabinoid Research [online]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576603/ [accessed 9th of Feb 2022].
Surendaran, S., et al. (2021). Myrcene - What Are the Potential Health Benefits of This Flavouring and Aroma Agent? Frontiers in Nutrition [online]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326332/[accessed 9th of Feb 2022].
Sharma, C., et al. (2016). Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise. Current Pharmaceutical Design [online]. Available from:https://pubmed.ncbi.nlm.nih.gov/26965491/ [accessed 19th of Feb 2022].
Anandakumar, P., Kamaraj, P., Vanitha, MK. (2020). D-limonene: A multifunctional compound with potent therapeutic effects. Journal of Food Biochemistry [online]. Available from: https://pubmed.ncbi.nlm.nih.gov/33289132/ [accessed 19th of Feb 2022].
Salehi, B., et al. (2019). Therapeutic Potential of α- and β-Pinene: A Miracle Gift of Nature. Biomolecules [online]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920849/ [accessed 19th of Feb 2022].
Mendes de Lacerda, G., et al. (2021). Pharmacological and toxicological activities of α-humulene and its isomers: A systematic review. Trends in Food Science & Technology [online]. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0924224421004234 [accessed 19th of Feb 2022].
Aprotosoaie, AC., et al. (2014). Linalool: a review on a key odorant molecule with valuable biological properties. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ffj.3197 [accessed 19th of Feb 2022].
Kind Blog - THC vs. CBD: differences between key cannabinoids
Pertwee, R. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology [online]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219532/ [accessed 11 March 2022].
Zou, S., Kumar, U. (2018). Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. Internation Journal of Molecular Science [online]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877694/ [accessed 11 March 2022].
Kroon, E., Kuhns, L., Cousijn, J. (2021). The short-term and long-term effects of cannabis on cognition: recent advances in the field. Current Opinion in Psychology [online]. Available from: https://www.sciencedirect.com/science/article/pii/S2352250X20301135 [accessed 11 March 2022].
Leweke, FM., et al. (2012). Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational Psychiatry [online]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316151/ [accessed 11 March 2022].
Lapraire, RB., et al. (2015). Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. British Journal of Pharmacology [online]. Available from: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.13250 [accessed 11 March 2022].
Russo, E. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal Pharmacology [online]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/ [accessed 11 March 2022].
Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics [online]. Available from: https://pubmed.ncbi.nlm.nih.gov/12648025/ [accessed 11 March 2022].